MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
Main Authors: | Na Wang, Jin-Ping Zhang, Xiao-Yan Xing, Zhao-Jun Yang, Bo Zhang, Xin Wang, Wen-Ying Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2018-04-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.termedia.pl/MARCH-factors-associated-with-weight-loss-in-patients-with-newly-diagnosed-type-2-diabetes-treated-with-acarbose-or-metformin,19,32560,1,1.html |
Similar Items
-
Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China
by: An, Y., et al.
Published: (2022) -
Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
by: Mo D, et al.
Published: (2019-08-01) -
Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
by: Guoli Du, et al.
Published: (2020-10-01) -
Evaluation of Serum Vaspin and Chemerin Levels in Type 2 Diabetic and Treated with Anti Diabetic Drugs Metformin and Acarbose in Rats
by: Seyed Mohammad Ali Ghaffari, et al.
Published: (2015-05-01) -
Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
by: Hae Kyung Yang, et al.
Published: (2019-06-01)